1. Home
  2. FFA vs CYRX Comparison

FFA vs CYRX Comparison

Compare FFA & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Trust Enhanced Equity Income Fund

FFA

First Trust Enhanced Equity Income Fund

HOLD

Current Price

$21.68

Market Cap

428.9M

Sector

Finance

ML Signal

HOLD

CYRX

CryoPort Inc.

HOLD

Current Price

$10.05

Market Cap

419.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FFA
CYRX
Founded
N/A
1999
Country
United States
United States
Employees
N/A
1100
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
428.9M
419.3M
IPO Year
2004
2008

Fundamental Metrics

Financial Performance
Metric
FFA
CYRX
Price
$21.68
$10.05
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$12.94
AVG Volume (30 Days)
35.8K
404.5K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
156.22
EPS
N/A
1.40
Revenue
N/A
$176,177,000.00
Revenue This Year
N/A
$11.06
Revenue Next Year
N/A
$8.45
P/E Ratio
N/A
$7.11
Revenue Growth
N/A
N/A
52 Week Low
$17.46
$5.21
52 Week High
$22.31
$11.45

Technical Indicators

Market Signals
Indicator
FFA
CYRX
Relative Strength Index (RSI) 63.62 71.38
Support Level $21.02 $9.18
Resistance Level $21.78 $10.23
Average True Range (ATR) 0.35 0.42
MACD 0.20 0.18
Stochastic Oscillator 98.25 90.10

Price Performance

Historical Comparison
FFA
CYRX

About FFA First Trust Enhanced Equity Income Fund

First Trust Enhanced Equity Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide high level of current income and gains and, to a lesser extent, capital appreciation. The Fund pursues its investment objective by investing in a diversified portfolio of equity securities.

About CYRX CryoPort Inc.

CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.

Share on Social Networks: